These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9886457)

  • 1. Spontaneous dyskinesia in first episode schizophrenia.
    Puri BK; Barnes TR; Chapman MJ; Hutton SB; Joyce EM
    J Neurol Neurosurg Psychiatry; 1999 Jan; 66(1):76-8. PubMed ID: 9886457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients.
    Chatterjee A; Chakos M; Koreen A; Geisler S; Sheitman B; Woerner M; Kane JM; Alvir J; Lieberman JA
    Am J Psychiatry; 1995 Dec; 152(12):1724-9. PubMed ID: 8526237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area.
    Gervin M; Browne S; Lane A; Clarke M; Waddington JL; Larkin C; O'Callaghan E
    Am J Psychiatry; 1998 Sep; 155(9):1202-6. PubMed ID: 9734543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of spontaneous dyskinesia in schizophrenia.
    Fenton WS
    J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics.
    Owens DG; Johnstone EC; Frith CD
    Arch Gen Psychiatry; 1982 Apr; 39(4):452-61. PubMed ID: 6121546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor abnormalities in first-episode psychosis patients and long-term psychosocial functioning.
    Cuesta MJ; García de Jalón E; Campos MS; Moreno-Izco L; Lorente-Omeñaca R; Sánchez-Torres AM; Peralta V
    Schizophr Res; 2018 Oct; 200():97-103. PubMed ID: 28890132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders.
    Peralta V; Campos MS; De Jalón EG; Cuesta MJ
    Mov Disord; 2010 Jun; 25(8):1068-76. PubMed ID: 20222137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Historical perspective on movement disorders.
    Friedman JH
    J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosis.
    Fallon P; Dursun SM
    J Psychopharmacol; 2011 Jun; 25(6):755-62. PubMed ID: 20147573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lack of involuntary abnormal movements in untreated schizophrenic patients].
    Hernán Silva I; Jerez CS; Ruiz TA; Seguel LM; Court LJ; Labarca BR
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1994; 22(5):200-2. PubMed ID: 7817846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A disturbance in the control of muscle force in neuroleptic-naive schizophrenic patients.
    Caligiuri MP; Lohr JB
    Biol Psychiatry; 1994 Jan; 35(2):104-11. PubMed ID: 7909452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapyramidal symptoms in unmedicated schizophrenia.
    McCreadie RG; Srinivasan TN; Padmavati R; Thara R
    J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.
    Fedorenko OY; Loonen AJ; Lang F; Toshchakova VA; Boyarko EG; Semke AV; Bokhan NA; Govorin NV; Aftanas LI; Ivanova SA
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
    Chorfi M; Moussaoui D
    Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not all that moves is tardive dyskinesia.
    Khot V; Wyatt RJ
    Am J Psychiatry; 1991 May; 148(5):661-6. PubMed ID: 1673323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskinesia and soft neurological signs in schizophrenia: a comparative study.
    Aydemir C; Goka E; Kisa C; Kurt A; Yuksel FV
    Int J Psychiatry Clin Pract; 2005; 9(4):238-43. PubMed ID: 24930920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involuntary disorders of movement in chronic schizophrenia--the role of the illness and its treatment.
    Owens DG
    Psychopharmacology Suppl; 1985; 2():79-87. PubMed ID: 2860663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mn-superoxide dismutase activity is associated with orofacial involuntary movements in schizophrenia patients with tardive dyskinesia.
    Wu JQ; Chen DC; Tan YL; Soares JC; Zhang XY
    Hum Psychopharmacol; 2015 Jan; 30(1):57-63. PubMed ID: 25572310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients.
    Janno S; Holi M; Tuisku K; Wahlbeck K
    Am J Psychiatry; 2004 Jan; 161(1):160-3. PubMed ID: 14702266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.